Research theme for competitive and other funds (10):
2022 - 2025 MED12野生型の子宮筋腫に対する新規治療戦略の確立
2021 - 2025 Development of a dissemination program for cervical cancer prevention measures to be spread throughout the community, centered on public health nurses.
2021 - 2025 Development of a program to spread cervical cancer preventive measures to the community centered on public health nurses
2019 - 2022 Leiomyoma therapy targeting growth effect of erythropoietin
2019 - 2022 Exploring the novel mechanisms of the massive growth of uterine leiomyoma by Erythropoietin
2016 - 2020 Development of cervical cancer and HPV related cancer preventive education program by peer education
2015 - 2018 Role of the cell polarity regulator aPKC in uterine cervical cancer and cervical intraepithelial lesion.
2015 - 2018 Molecular biological mechanisms of uterine leiomyoma growth.
2012 - 2015 Molecular biological mechanisms of tumor growth in uterine leiomyoma
2011 - 2013 Role and possibility as a therapeutic target of aPKClambda/iota in intractable cancers
Show all
Papers (130):
Yoichi Kobayashi, Mikiko Asai-Sato, Shiho Kuji, Hitomi Sakai, Ken Yamaguchi, Nao Suzuki, Yoshio Yoshida. Awareness and attitude toward cardio-oncology among Japanese gynecologic oncologists in managing patients with endometrial cancer: The Japanese Gynecologic Oncology Group (JGOG) questionnaire surveys. The journal of obstetrics and gynaecology research. 2025. 51. 2. e16225
Mikiko Asai-Sato, Toshifumi Takahashi, Kuniaki Ota, Hiromi Komiya, Takeshi Iwasa, Soichi Ogishima, Nao Suzuki. Attitudes toward subsequent primary cancer prevention among survivors of childhood, adolescent, and young adult (CAYA) cancer in Japan: results of a comprehensive questionnaire survey on long-term women's health after CAYA cancer. Journal of gynecologic oncology. 2024
Kei Kawana, Osamu Kobayashi, Yuji Ikeda, Hideaki Yahata, Takashi Iwata, Toyomi Satoh, Azusa Akiyama, Daichi Maeda, Yumiko Hori-Hirose, Yukari Uemura, et al. Phase I/II randomized clinical trial of an oral therapeutic vaccine targeting HPV for treatment of CIN2/3. JNCI cancer spectrum. 2023